The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Luca, Maria ^a   Luca, Antonina ^a   Calandra, Carmela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; PROTEINS;

ALZHEIMER'S DISEASE; ANTIOXIDANT DEFENCE SYSTEM; ANTIOXIDANT THERAPIES; HEAT SHOCK PROTEIN; OXIDATIVE DAMAGE; RESEARCH FIELDS; THERAPEUTIC STRATEGY; VASCULAR DEMENTIA;

NEURODEGENERATIVE DISEASES;

ANTIOXIDANT;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; CELL AGING; DISEASE COURSE; HUMAN; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RISK FACTOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; DEMENTIA, VASCULAR; DISEASE PROGRESSION; HUMANS; OXIDATIVE STRESS;

EID: 84939489517     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/504678     Document Type: Review

References (106)

1. M. Fiedorowicz and P. Grieb,"Nitrooxidative stress and neurodegeneration"in Brain Damage-Bridging Between Basic Research and Clinics, A. Gonzalez-Quevedo, Ed. , chapter 6, InTech, Rijeka, Croatia, 2012
2. V. J. Thannickal and B. L. Fanburg,"Reactive oxygen species in cell signaling"The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1005-L1028, 2000
3. S. Bolisetty and E. A. Jaimes,"Mitochondria and reactive oxygen species: physiology and pathophysiology"International Journal ofMolecular Sciences, vol. 14, no. 3, pp. 6306-6344, 2013
4. C. P. Baran, M. M. Zeigler, S. Tridandapani, and C. B. Marsh,"The role of ROS and RNS in regulating life and death of blood monocytes"Current Pharmaceutical Design, vol. 10, no. 8, pp. 855-866, 2004
5. K. Ogino andD.-H. Wang,"Biomarkers of oxidative/nitrosative stress: an approach to disease prevention"Acta Medica Okayama, vol. 61, no. 4, pp. 181-189, 2007
6. H. Klandorf and K. van Dyke,"Oxidative and nitrosative stresses: their role in health and disease in man and birds"in Oxidative Stress-Molecular Mechanisms and Biological Effects, V. Lushchak and H. M. Semchyshyn, Eds. , chapter 3, InTech, Rijeka, Croatia, 2012
7. H. Sies,"Oxidative stress: oxidants and antioxidants"Experimental Physiology, vol. 82, no. 2, pp. 291-295, 1997
8. D. P. Jones,"Redefining oxidative stress"Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1865-1879, 2006
9. P. Ljubuncic, E. Gochman, andA. Z. Reznick,"Nitrosative stress in aging-its importance and biological implications in NF-kB signaling"in Aging and Age-Related Disorders, S. Bondy and K. Maiese, Eds. , vol. 3 of Oxidative Stress in Applied Basic Research and Clinical Practice, Springer, 2010
10. A. C. Maritim, R. A. Sanders, and J. B. Watkins,"Diabetes, oxidative stress, and antioxidants: a review"Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24-38, 2003
11. H. Li, S. Horke, and U. Forstermann,"Vascular oxidative stress, nitric oxide and atherosclerosis"Atherosclerosis, vol. 237, no. 1, pp. 208-219, 2014
12. L. L. Torres, N. B. Quaglio, G. T. de Souza et al. ,"Peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer's disease"Journal of Alzheimer's Disease, vol. 26, no. 1, pp. 59-68, 2011
13. A. Gaspar, N. Milhazes, L. Santana, E. Uriarte, F. Borges, and M. J. Matos,"Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry"Current Topics in Medicinal Chemistry, vol. 15, no. 5, pp. 432-445, 2015
14. S. E. Browne, R. J. Ferrante, andM. F. Beal,"Oxidative stress in Huntington's disease"Brain Pathology, vol. 9, no. 1, pp. 147-163, 1999
15. E. Radi, P. Formichi, C. Battisti, and A. Federico,"Apoptosis and oxidative stress in neurodegenerative diseases"Journal of Alzheimer's Disease, vol. 42, supplement 3, pp. S125-S152, 2014
16. C. Cervellati, A. Romani, D. Seripa et al. ,"Oxidative balance, homocysteine, and uric acid levels in older patients with Late OnsetAlzheimer's Disease orVascularDementia"Journal of the Neurological Sciences, vol. 337, no. 1-2, pp. 156-161, 2014
17. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan,"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options"Current Neuropharmacology, vol. 7, no. 1, pp. 65-74, 2009
18. D. Allan Butterfield, B. Howard, S. Yatin et al. ,"Elevated oxidative stress in models of normal brain aging and Alzheimer's disease"Life Sciences, vol. 65, no. 18-19, pp. 1883-1892, 1999
19. M. J. Ball,"Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study"Acta Neuropathologica, vol. 37, no. 2, pp. 111-118, 1977
20. R. H. Swerdlow,"Brain aging, Alzheimer's disease, and mitochondria"Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1812, no. 12, pp. 1630-1639, 2011
21. J. L. Price, P. B. Davis, J. C. Morris, and D. L. White,"The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease"Neurobiology of Aging, vol. 12, no. 4, pp. 295-312, 1991
22. Y.-T. Chang, W.-N. Chang, N.-W. Tsai et al. ,"The roles of biomarkers of oxidative stress and antioxidant in alzheimer's disease: a systematic review"BioMed Research International, vol. 2014, Article ID182303, 14 pages, 2014
23. M.-C. Bada, E. Giraldo, F. Das et al. ,"Reductive stress in young healthy individuals at risk of Alzheimer disease"Free Radical Biology &Medicine, vol. 63, pp. 274-279, 2013
24. J. K. Andersen,"Oxidative stress in neurodegeneration: cause or consequence" Nature Medicine, vol. 10, pp. S18-S25, 2004
25. L. Ghezzi,"Alzheimer's disease: clinical aspects and treatments"in Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers, D. Galimberti and E. Scarpini, Eds. , chapter 2, pp. 17-26, Springer, London, UK, 2014
26. P. A. Adlard, B. A. Tran, D. I. Finkelstein et al. ,"A review of-Amyloid neuroimaging in Alzheimer's disease"Frontiers in Neuroscience, vol. 8, article 327, 2014
27. W. R. Markesbery,"The role of oxidative stress in Alzheimer disease"Archives of Neurology, vol. 56, no. 12, pp. 1449-1452, 1999
28. D. A. Butterfield andC. M. Lauderback,"Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid-peptide-Associated free radical oxidative stress"Free Radical Biology andMedicine, vol. 32, no. 11, pp. 1050-1060, 2002
29. S. M. Yatin, S. Varadarajan, C. D. Link, and D. A. Butterfield,"Invitroand invivooxidative stress associatedwithAlzheimer's amyloid-peptide (1-42)"Neurobiology of Aging, vol. 20, no. 3, pp. 325-330, 1999
30. J. Drake, C. D. Link, and D. A. Butterfield,"Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid-peptide (1-42) in a transgenic Caenorhabditis elegans model"Neurobiology of Aging, vol. 24, no. 3, pp. 415-420, 2003
31. D. Pratico, K. Uryu, S. Leight, J. Q. Trojanoswki, and V. M.-Y. Lee,"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis"The Journal of Neuroscience, vol. 21, no. 12, pp. 4183-4187, 2001
32. S. Hee Lee, I. Kim, and B. Chul Chung,"Increased urinary level of oxidized nucleosides in patients withmild-to-moderate Alzheimer's disease"Clinical Biochemistry, vol. 40, no. 13-14, pp. 936-938, 2007
33. M. Y. Aksenov, M. V. Aksenova, D. A. Butterfield, J. W. Geddes, and W. R. Markesbery,"Protein oxidation in the brain in Alzheimer's disease"Neuroscience, vol. 103, no. 2, pp. 373-383, 2001
34. B. Su, X. Wang, H.-G. Lee et al. ,"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells"Neuroscience Letters, vol. 468, no. 3, pp. 267-271, 2010
35. S. Tenreiro, K. Eckermann, and T. F. Outeiro,"Protein phosphorylation in neurodegeneration: friend or foe?" Frontiers in Molecular Neuroscience, vol. 7, article 42, 2014
36. B. Bhandary, A. Marahatta, H.-R. Kim, and H.-J. Chae,"An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases"International Journal of Molecular Sciences, vol. 14, no. 1, pp. 434-456, 2013
37. N. Gregersen and P. Bross,"Protein misfolding and cellular stress: an overview"Methods in Molecular Biology, vol. 648, pp. 3-23, 2010
38. F. Shang and A. Taylor,"Ubiquitin-proteasome pathway and cellular responses to oxidative stress"Free Radical Biology &Medicine, vol. 51, no. 1, pp. 5-16, 2011
39. A. Higa and E. Chevet,"Redox signaling loops in the unfolded protein response"Cellular Signalling, vol. 24, no. 8, pp. 1548-1555, 2012
40. M. Padurariu, A. Ciobica, R. Lefter, I. L. Serban, C. Stefanescu, and R. Chirita,"The oxidative stress hypothesis in Alzheimer's disease"Psychiatria Danubina, vol. 25, no. 4, pp. 401-409, 2013
41. R. Castellani, K. Hirai, G. Aliev et al. ,"Role of mitochondrial dysfunction in Alzheimer's disease"Journal of Neuroscience Research, vol. 70, no. 3, pp. 357-360, 2002
42. X. Wang, W. Wang, L. Li, G. Perry, H.-G. Lee, and X. Zhu,"Oxidative stress andmitochondrial dysfunction in Alzheimer's disease"Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1240-1247, 2014
43. T. Malm, M. Mariani, L. J. Donovan, L. Neilson, and G. E. Landreth,"Activation of the nuclear receptor PPAR is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation"Journal of Neuroinflammation, vol. 12, no. 1, p. 7, 2015
44. G. Dentesano, J. Serratosa, J. M. Tusell et al. ,"CD200R1 and CD200 expression are regulated by PPAR-in activated glial cells"Glia, vol. 62, no. 6, pp. 982-998, 2014
45. D. M. Small, C. Morais, J. S. Coombes, N. C. Bennett, D. W. Johnson, and G. C. Gobe,"Oxidative stress-induced alterations in PPAR-And associated mitochondrial destabilization contribute to kidney cell apoptosis"American Journal of Physiology-Renal Physiology, vol. 307, no. 7, pp. F814-F822, 2014
46. J.-L. Tan, Q.-X. Li, G. D. Ciccotosto et al. ,"Mild oxidative stress induces redistribution of BACE1 in non-Apoptotic conditions and promotes the amyloidogenic processing of Alzheimer's disease amyloid precursor protein"PLoS ONE, vol. 8, no. 4, Article ID e61246, 2013
47. S. Miranda, C. Opazo, L. F. Larrondo et al. ,"The role of oxidative stress in the toxicity induced by amyloid-peptide in Alzheimer's disease"Progress in Neurobiology, vol. 62, no. 6, pp. 633-648, 2000
48. Y. Christen,"Oxidative stress and Alzheimer disease"The American Journal of ClinicalNutrition, vol. 71, supplement 2, pp. 621S-629S, 2000
49. M. A. Deibel, W. D. Ehmann, and W. R. Markesbery,"Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress"Journal of the Neurological Sciences, vol. 143, no. 1-2, pp. 137-142, 1996
50. B. S. Berlett and E. R. Stadtman,"Protein oxidation in aging, disease, and oxidative stress"The Journal of Biological Chemistry, vol. 272, no. 33, pp. 20313-20316, 1997
51. X. Zhu, A. K. Raina, H.-G. Lee, G. Casadesus, M. A. Smith, and G. Perry,"Oxidative stress signalling in Alzheimer's disease"Brain Research, vol. 1000, no. 1-2, pp. 32-39, 2004
52. P. Rinaldi, M. C. Polidori, A. Metastasio et al. ,"Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease"Neurobiology of Aging, vol. 24, no. 7, pp. 915-919, 2003
53. F. Mangialasche, W. Xu, M. Kivipelto et al. ,"Tocopherols and tocotrienols plasma levels are associated with cognitive impairment"Neurobiology of Aging, vol. 33, no. 10, pp. 2282-2290, 2012
54. G. C. Roman,"Vascular dementia: distinguishing characteristics, treatment, and prevention"Journal of the American Geriatrics Society, vol. 51, supplement 5, pp. S296-S304, 2003
55. K. Amar and G. Wilcock,"Vascular dementia"British Medical Journal, vol. 312, no. 7025, pp. 227-231, 1996
56. I. Dias, M. Polidori, and H. Griffiths,"Hypercholesterolaemiainduced oxidative stress at the blood-brain barrier"Biochemical Society Transactions, vol. 42, no. 4, pp. 1001-1005, 2014
57. F. Derouiche, C. Bole-Feysot, D. Nami, and M. Coeffier,"Hyperhomocysteinemia-induced oxidative stress differentially alters proteasomecomposition and activities in heart and aorta"Biochemical and Biophysical Research Communications, vol. 452, no. 3, pp. 740-745, 2014
58. S. Rubattu, B. Pagliaro, G. Pierelli et al. ,"Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress"International Journal ofMolecular Sciences, vol. 16, no. 1, pp. 823-839, 2015
59. F. Di Lisa, N. Kaludercic, A. Carpi, R. Menabo, and M. Giorgio,"Mitochondria and vascular pathology"Pharmacological Reports, vol. 61, no. 1, pp. 123-130, 2009
60. H. C. F. Oliveira, R. G. Cosso, L. C. Alberici et al. ,"Oxidative stress in atherosclerosis-prone mouse is due to low antioxidant capacity of mitochondria"The FASEB Journal, vol. 19, no. 2, pp. 278-280, 2005
61. G. Luc and J.-C. Fruchart,"Oxidation of lipoproteins and atherosclerosis, "The American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 206S-209S, 1991
62. M. C. Polidori, B. Frei, A. Cherubini et al. ,"Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke"Free Radical Biology &Medicine, vol. 25, no. 4-5, pp. 561-567, 1998
63. K. Gustaw-Rothenberg, K. Kowalczuk, and M. Stryjecka-Zimmer,"Lipids' peroxidation markers in Alzheimer's disease and vascular dementia"Geriatrics &Gerontology International, vol. 10, no. 2, pp. 161-166, 2010
64. L. Li, R. S. Willets, M. C. Polidori et al. ,"Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance"Free Radical Research, vol. 44, no. 3, pp. 241-248, 2010
65. L. Nanetti, R. Taffi, A. Vignini et al. ,"Reactive oxygen species plasmatic levels in ischemic stroke"Molecular and Cellular Biochemistry, vol. 303, no. 1-2, pp. 19-25, 2007
66. L. Raz, Q.-G. Zhang, C.-F. Zhou et al. ,"Role of Rac1 GTPase in NADPHoxidase activation and cognitive impairment following cerebral ischemia in the rat"PLoS ONE, vol. 5, no. 9, Article ID e12606, 2010
67. T. Nagayama, J. Lan, D. C. Henshall et al. ,"Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia"Journal of Neurochemistry, vol. 75, no. 4, pp. 1716-1728, 2000
68. G. A. Rosenberg, N. Sullivan, and M. M. Esiri,"White matter damage is associatedwith matrix metalloproteinases in vascular dementia"Stroke, vol. 32, no. 5, pp. 1162-1167, 2001
69. P. J. Kelly, J. D. Morrow, M. Ning et al. ,"Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study"Stroke, vol. 39, no. 1, pp. 100-104, 2008
70. S. Chrissobolis and F. M. Faraci,"The role of oxidative stress and NADPH oxidase in cerebrovascular disease"Trends in Molecular Medicine, vol. 14, no. 11, pp. 495-502, 2008
71. M. L. Modrick, D. A. Kinzenbaw, Y. Chu, C. D. Sigmund, and F. M. Faraci,"Peroxisome proliferator-Activated receptor-protects against vascular aging"American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 302, no. 10, pp. R1184-R1190, 2012
72. C. Iadecola,"The pathobiology of vascular dementia"Neuron, vol. 80, no. 4, pp. 844-866, 2013
73. D. Ryglewicz, M. Rodo, P. K. Kunicki et al. ,"Plasma antioxidant activity and vascular dementia"Journal of the Neurological Sciences, vol. 203-204, pp. 195-197, 2002
74. A. Casado, M. E. Lopez-Fernandez, M. C. Casado, and R. de la Torre,"Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias"Neurochemical Research, vol. 33, no. 3, pp. 450-458, 2008
75. R. N. Kalaria and C. Ballard,"Overlap between pathology of Alzheimer disease and vascular dementia"Alzheimer Disease and Associated Disorders, vol. 13, no. 3, pp. S115-S123, 1999
76. S. Bennett, M. M. Grant, and S. Aldred,"Oxidative stress in vascular dementia and alzheimer's disease: a common pathology"Journal of Alzheimer's Disease, vol. 17, no. 2, pp. 245-257, 2009
77. B. H. Han, M. L. Zhou, A. W. Johnson et al. ,"Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice"Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 8, pp. E881-E890, 2015
78. G. Paragh, P. Balla, E. Katona, I. Seres, A. Egerhazi, and I. Degrell,"Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia"European Archives ofPsychiatry andClinical Neuroscience, vol. 252, no. 2, pp. 63-67, 2002
79. R. Esen, M. Aslan, M. E. Kucukoglu et al. ,"Serumparaoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis, "Wiener KlinischeWochenschrift, 2015
80. D. Litvinov, H. Mahini, and M. Garelnabi,"Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases"North American Journal of Medical Sciences, vol. 4, no. 11, pp. 523-532, 2012
81. M. Aviram and M. Rosenblat,"Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development"Free Radical Biology &Medicine, vol. 37, no. 9, pp. 1304-1316, 2004
82. D. Commenges, V. Scotet, S. Renaud, H. Jacqmin-Gadda, P. Barberger-Gateau, and J.-F. Dartigues,"Intake of flavonoids and risk of dementia"European Journal of Epidemiology, vol. 16, no. 4, pp. 357-363, 2000
83. O. Rozenberg, M. Rosenblat, R. Coleman, D. M. Shih, and M. Aviram,"Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice"Free Radical Biology &Medicine, vol. 34, no. 6, pp. 774-784, 2003
84. L. T. McGrath, B. M. McGleenon, S. Brennan, D. McColl, S. McIlroy, and A. P. Passmore,"Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde"QJM, vol. 94, no. 9, pp. 485-490, 2001
85. M. Chaves, A. Toral, A. Bisonni et al. ,"Treatmentwith vitamin D and slowing of progression to severe stage of Alzheimer's disease"Vertex, vol. 25, no. 114, pp. 85-91, 2014 (Spanish)
86. K. H. Masaki, K. G. Losonczy, G. Izmirlian et al. ,"Association of vitamin E and C supplement use with cognitive function and dementia in elderly men"Neurology, vol. 54, no. 6, pp. 1265-1272, 2000
87. C. Zhang, A. Browne, D. Child, and R. E. Tanzi,"Curcumin decreases amyloid-peptide levels by attenuating the maturation of amyloid-precursor protein"The Journal of Biological Chemistry, vol. 285, no. 37, pp. 28472-28480, 2010
88. Y. Li,"Protective effects of curcumin on brain vascular dementia by chronic cerebral ischemia in rats and study of the molecular mechanism"Alzheimer's &Dementia, vol. 7, no. 4, pp. e47-e48, 2011
89. A. Clausen, X. Xu, X. Bi, and M. Baudry,"Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline"Journal of Alzheimer's Disease, vol. 30, no. 1, pp. 183-208, 2012
90. X. R. Ma, Z. K. Sun, Y. R. Liu, Y. J. Jia, B. A. Zhang, and J. W. Zhang,"Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia"Neural Regeneration Research, vol. 8, no. 22, pp. 2050-2059, 2013
91. M. J. Barrett, V. Alones, K. X. Wang, L. Phan, and R. H. Swerdlow,"Mitochondria-derived oxidative stress induces a heat shock protein response"Journal of Neuroscience Research, vol. 78, no. 3, pp. 420-429, 2004
92. J. F. Abisambra, U. K. Jinwal, J. R. Jones, L. J. Blair, J. Koren, and C. A. Dickey,"Exploiting the diversity of the heatshock protein family for primary and secondary tauopathy therapeutics"Current Neuropharmacology, vol. 9, no. 4, pp. 623-631, 2011
93. J. R. Ou, M. S. Tan, A. M. Xie, J. T. Yu, and L. Tan,"Heat shock protein 90 in Alzheimer's disease"BioMed Research International, vol. 2014, Article ID 796869, 7 pages, 2014
94. Y. Chen, B. Wang, D. Liu et al. ,"Hsp90 chaperone inhibitor 17-AAG Attenuates A-induced synaptic toxicity and memory impairment"Journal of Neuroscience, vol. 34, no. 7, pp. 2464-2470, 2014
95. W. Luo, W. Sun, T. Taldone, A. Rodina, and G. Chiosis,"Heat shock protein 90 in neurodegenerative diseases"Molecular Neurodegeneration, vol. 5, no. 1, article 24, 2010
96. A. Salminen, J. Ojala, K. Kaarniranta, M. Hiltunen, and H. Soininen,"Hsp90 regulates tau pathology through cochaperone complexes in Alzheimer's disease"Progress in Neurobiology, vol. 93, no. 1, pp. 99-110, 2011
97. J. Zou, Y. Guo, T. Guettouche, D. F. Smith, and R. Voellmy,"Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1"Cell, vol. 94, no. 4, pp. 471-480, 1998
98. N. Fujikake, Y. Nagai, H. A. Popiel, Y. Okamoto, M. Yamaguchi, and T. Toda,"Heat shock transcription factor 1-Activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones"The Journal of Biological Chemistry, vol. 283, no. 38, pp. 26188-26197, 2008
99. N. V. Bobkova, D. G. Garbuz, I. Nesterova et al. ,"Therapeutic effect of exogenous Hsp70 in mouse models of Alzheimer's disease"Journal of Alzheimer's Disease, vol. 38, no. 2, pp. 425-435, 2014
100. J. Agulla, D. Brea, F. Campos et al. ,"In vivo theranostics at the peri-infarct region in cerebral ischemia, "Theranostics, vol. 4, no. 1, pp. 90-105, 2014
101. G. A. Dienel, M. Kiessling, M. Jacewicz, and W. A. Pulsinelli,"Synthesis of heat shock proteins in rat brain cortex after transient ischemia"Journal of Cerebral Blood Flow andMetabolism, vol. 6, no. 4, pp. 505-510, 1986
102. J.-C. L. Plumier, A. M. Krueger, R. W. Currie, D. Kontoyiannis, G. Kollias, and G. N. Pagoulatos,"Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury"Cell Stress &Chaperones, vol. 2, no. 3, pp. 162-167, 1997
103. P. Papadopoulos, P. Rosa-Neto, J. Rochford, and E. Hamel,"Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in amouse model of Alzheimer's disease with combined amyloid-And cerebrovascular pathology"PLoS ONE, vol. 8, no. 7, Article ID e68612, 2013
104. B. Sharma and N. Singh,"Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats"Pharmacology Biochemistry and Behavior, vol. 100, no. 2, pp. 320-329, 2011
105. R. Ros-Vazquez, R. Marzoa-Rivas, I. Gil-Ortega, and J. C. Kaski,"Peroxisome proliferator-Activated receptor-Agonists for management and prevention of vascular disease in patients with and without diabetes mellitus"American Journal of Cardiovascular Drugs, vol. 6, no. 4, pp. 231-242, 2006
106. T. Persson, B. O. Popescu, and A. Cedazo-Minguez,"Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail?" OxidativeMedicine and Cellular Longevity, vol. 2014, Article ID 427318, 11 pages, 2014